Steven Gelone

Steven Gelone

No open positions remaining
58 year
Health Technology
Consumer Services

Profile

Dr. Steven P.
Gelone
is a President & Chief Executive Officer at Hula Therapeutics, Inc. Dr. Gelone was previously employed as a Chief Scientific Officer by Nabriva Therapeutics GmbH, a Head-Clinical Research & Development by Spark Therapeutics, Inc., a Vice President-Clinical & Preclinical Development by ViroPharma, Inc. /US/, a Director-Medical Affairs by Vicuron Pharmaceuticals Inc, and a Director-Clinical Pharmacology by GlaxoSmithKline Plc.
He also served on the board at Nabriva Therapeutics Plc.
He received his undergraduate degree from Temple University (Pennsylvania) and a doctorate degree from Temple University (Pennsylvania).

Steven Gelone active positions

CompaniesPositionStart

Former positions of Steven Gelone

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 30/06/2017
Corporate Officer/Principal 01/01/2014
Chief Tech/Sci/R&D Officer 01/01/2003
GSK PLC Chief Tech/Sci/R&D Officer 01/01/2002
SPARK THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Steven Gelone's experience

Training of Steven Gelone

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology